AstraZeneca
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
11.7210.3914.0412.99
Price/Sales ratio
4.444.203.943.78
Earnings per Share (EPS)
$6.78$7.65$5.66$6.11

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
72.0330.3819.7529.8544.6597.1841.041.47K63.8435.0331.6297.18
Price/Sales ratio
3.403.473.003.984.355.324.924.414.734.554.015.32
Price/Book Value ratio
4.524.644.655.987.719.888.394.205.665.335.049.88
Price/Cash Flow ratio
12.5825.8116.6725.0336.7643.6927.3327.7021.4020.1618.1243.69
Price/Free Cash Flow ratio
20.62160.1237.7445.7577.17254.8859.8143.9029.0031.7730.40254.88
Price/Earnings Growth ratio
-1.380.230.81-2.07-1.56-2.420.29-15.240.020.43-51.54-2.42
Dividend Yield
3.96%4.06%5.15%3.92%3.62%2.76%2.72%2.33%2.07%2.14%2.22%2.76%
Profitability Indicator Ratios
Gross Profit Margin
77.61%81.19%82.06%80.77%77.65%79.81%80.09%66.76%72.06%82.44%80.88%77.65%
Operating Profit Margin
8.18%16.65%21.31%16.36%15.33%11.99%19.39%2.82%8.47%17.88%17.96%15.33%
Pretax Profit Margin
4.77%12.42%15.44%9.91%9.02%6.34%14.71%-0.70%5.63%15.05%15.47%9.02%
Net Profit Margin
4.72%11.43%15.21%13.35%9.75%5.47%12.00%0.29%7.41%12.99%12.68%9.75%
Effective Tax Rate
0.88%7.91%4.11%-28.78%-2.86%20.73%19.71%143.39%-31.66%13.59%17.95%-2.86%
Return on Assets
2.10%4.69%5.59%4.73%3.55%2.17%4.78%0.10%3.40%5.88%6.19%3.55%
Return On Equity
6.28%15.27%23.55%20.06%17.28%10.16%20.45%0.28%8.87%15.21%16.56%16.56%
Return on Capital Employed
5.17%9.09%10.37%7.82%7.63%6.75%11.11%1.27%5.35%11.60%11.64%7.63%
Liquidity Ratios
Current Ratio
0.961.070.860.800.950.850.96N/AN/AN/A0.930.85
Quick Ratio
0.850.930.710.610.770.680.760.760.680.640.710.68
Cash ratio
0.360.410.320.200.290.290.380.280.230.190.180.29
Days of Sales Outstanding
105.75103.5475.2145.5249.4853.6677.4985.7981.6666.98N/A53.66
Days of Inventory outstanding
122.45168.35206.47256.54213.70236.83277.17263.63138.41246.23211.09236.83
Operating Cycle
228.21271.89281.68302.07263.19290.49354.66349.42220.08313.22211.09290.49
Days of Payables Outstanding
218.17272.53148.61193.15127.18131.58161.8782.8775.11148.31808.44127.18
Cash Conversion Cycle
10.04-0.63133.07108.92136.00158.91192.79266.54144.96164.90-597.34158.91
Debt Ratios
Debt Ratio
0.180.240.260.280.310.280.290.290.300.280.280.28
Debt Equity Ratio
0.540.801.121.191.531.331.260.780.780.720.741.33
Long-term Debt to Capitalization
0.290.430.490.500.580.540.520.410.380.360.410.54
Total Debt to Capitalization
0.350.440.520.540.600.570.550.430.440.420.420.57
Interest Coverage Ratio
2.183.012.613.211.101.212.90N/AN/AN/A5.341.10
Cash Flow to Debt Ratio
0.650.220.240.200.130.160.240.190.330.360.370.13
Company Equity Multiplier
2.983.254.204.234.864.674.272.682.602.582.574.67
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.270.130.180.150.110.120.180.150.220.220.220.11
Free Cash Flow / Operating Cash Flow Ratio
0.610.160.440.540.470.170.450.630.730.630.590.47
Cash Flow Coverage Ratio
0.650.220.240.200.130.160.240.190.330.360.370.13
Short Term Coverage Ratio
2.913.871.851.571.491.592.152.241.561.699.041.49
Dividend Payout Ratio
285.56%123.39%101.77%117.26%161.67%269.06%111.76%3442.85%132.72%75.24%71.25%269.06%